Skip to main content
. 2017 Mar;33(2):165–172. doi: 10.6515/ACS20160611B

Table 3. Cox regression model for predictor of atrial fibrillation development.

Variables Model 1 Model 2 Model 3
HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value
Gender
 Female 1.00 1.00 1.00
 Male 1.25 1.18-1.33 < 0.001 1.2 1.14-1.27 < 0.001 1.25 1.18-1.33 < 0.001
Age, y
 18-40 1.00 1.00 1.00
 41-65 6.45 5.05-8.24 < 0.001 7.62 5.99-9.69 < 0.001 6.47 5.07-8.27 < 0.001
 ≥ 65 26.95 21.11-34.42 < 0.001 33.1 26.01-42.11 < 0.001 27.09 21.21-34.59 < 0.001
Comorbidity
 DM 0.95 0.89-1.02 0.15 0.96 0.90-1.02 0.22 0.95 0.89-1.02 0.15
 Hypertension 1.25 1.16-1.34 < 0.001 1.23 1.15-1.32 < 0.001 1.25 1.17-1.35 < 0.001
 Dyslipidemia 0.66 0.62-0.70 < 0.001 0.62 0.59-0.66 < 0.001 0.66 0.62-0.70 < 0.001
 COPD 1.15 1.07-1.25 < 0.001 1.16 1.08-1.24 < 0.001 1.15 1.07-1.25 < 0.001
 Congestive heart failure 2.20 2.05-2.36 < 0.001 2.14 2.00-2.28 < 0.001 2.20 2.05-2.36 < 0.001
 Coronary artery disease 1.72 1.61-1.84 < 0.001 1.66 1.57-1.77 < 0.001 1.73 1.62-1.85 < 0.001
 Chronic kidney disease 1.02 0.92-1.13 0.77 0.93 0.84-1.03 0.16 1.02 0.92-1.13 0.77
 Stroke 0.94 0.86-1.02 0.15 0.82 0.75-0.89 < 0.001 0.94 0.86-1.02 0.14
 Peripheral artery disease 0.93 0.76-1.13 0.45 0.92 0.76-1.11 0.38 0.93 0.76-1.13 0.46
 Sleep apnea 0.81 0.42-1.56 0.53 0.47 0.21-1.04 0.06 0.81 0.42-1.56 0.53
 Valvular heart diseases 0.99 0.83-1.19 0.93 1.08 0.92-1.27 0.35 0.99 0.83-1.19 0.95
 Depression 0.89 0.69-1.08 0.12 0.87 0.65-1.12 0.14 0.89 0.69-1.08 0.12
 Bipolar disorder 0.95 0.78-1.11 0.22 0.93 0.74-1.15 0.25 0.95 0.78-1.11 0.23
Insomnia
 No 1.00 1.00
 Yes 1.08 1.01-1.14 0.02 1.33 1.25-1.41 < 0.001
Insomnia
 No 1.00
 < 5 visits 1.16 1.05-1.28 0.004
 5-9 visits 1.14 1.03-1.26 0.009
 ≥ 10 visits 1.00 0.92-1.08 0.93

Model 1, Non-insomnia cohort matched on sex, age, index date; Model 2, Non-insomnia cohort matched on sex, age, co-morbidity by using propensity score; Model 3, Insomnia frequency analysis between insomnia and Afib. Abbreviations are in Table 1.